BeStock  
Stocks › Biotechnology › ANRO

Alto Neuroscience ANRO

US equityMarket cap rank #3145Biotechnology
$25.37 −$1.14 (-4.30%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $25.37 0.00%
Open$25.76
Prev close$26.51
Day range$24.40 – $26.48
Volume522.5K
Market cap$1.02B
P/E (TTM)–
Dividend yield–

ANRO Stock News

Headlines matching Alto Neuroscience or the ANRO ticker, most recent first.

  • H.C. Wainwright Maintains Alto Neuroscience(ANRO.US) With Buy Rating, Maintains Target Price $55Market news · 22 Sep 2026 · Direct mention
  • H.C. Wainwright Maintains Alto Neuroscience(ANRO.US) With Buy Rating, Raises Target Price to $55 PositiveMarket news · 17 Aug 2026 · Direct mention
  • Analysts Offer Insights on Healthcare Companies: 4D Molecular Therapeutics (FDMT), Alto Neuroscience, Inc. (ANRO) and Irhythm Technologies (IRTC)TipRanks · 14 Aug 2026 · Direct mention
  • BofA Securities Maintains Alto Neuroscience(ANRO.US) With Buy RatingMarket news · 14 Aug 2026 · Direct mention
  • BTIG Maintains Alto Neuroscience(ANRO.US) With Buy Rating, Maintains Target Price $37Market news · 13 Aug 2026 · Direct mention
  • BTIG Maintains Alto Neuroscience(ANRO.US) With Buy Rating, Raises Target Price to $37 PositiveMarket news · 13 Aug 2026 · Direct mention
  • Alto Neuroscience, Inc. (ANRO) Receives a Buy From JefferiesTipRanks · 13 Aug 2026 · Direct mention
  • Jefferies Maintains Alto Neuroscience(ANRO.US) With Buy Rating, Raises Target Price to $40 PositiveMarket news · 13 Aug 2026 · Direct mention
  • Analysts Offer Insights on Healthcare Companies: Alto Neuroscience, Inc. (ANRO) and Owlet (OWLT)TipRanks · 13 Aug 2026 · Direct mention
  • Analysts Offer Insights on Healthcare Companies: Oruka Therapeutics (ORKA), Alto Neuroscience, Inc. (ANRO) and Astrana Health (ASTH)TipRanks · 14 Jul 2026 · Direct mention
  • BTIG Maintains Alto Neuroscience(ANRO.US) With Buy Rating, Maintains Target Price $28Market news · 14 Jul 2026 · Direct mention
  • Analysts Offer Insights on Healthcare Companies: TransMedics Group (TMDX), Aquestive Therapeutics (AQST) and Alto Neuroscience, Inc. (ANRO)TipRanks · 26 Jun 2026 · Direct mention
  • JonesTrading Maintains Alto Neuroscience(ANRO.US) With Buy Rating, Maintains Target Price $44Market news · 26 Jun 2026 · Direct mention
  • H.C. Wainwright Remains a Buy on Alto Neuroscience, Inc. (ANRO)TipRanks · 25 Jun 2026 · Direct mention
  • H.C. Wainwright Maintains Alto Neuroscience(ANRO.US) With Buy Rating, Maintains Target Price $50Market news · 25 Jun 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on ANRO.

Sign in to join the discussion.

Scroll to Top